2008 Santa Fe Bone Symposium: Update on Osteoporosis

E. Michael Lewiecki, Sanford Baim, John P. Bilezikian, Richard Eastell, Meryl S. LeBoff, Paul D. Miller

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The Ninth Annual Santa Fe Bone Symposium was held on August 1-2, 2008, in Santa Fe, New Mexico, USA. The symposium faculty presented the current best evidence on selected topics of clinical relevance in the fields of osteoporosis, metabolic bone disease, and assessment of skeletal health. The educational venues were in the form of didactic presentations, panel discussions, challenging cases, and numerous interactive discussions. Knowledge of basic science and clinical trials was applied to real-world patient scenarios that were discussed by faculty experts and clinician participants. Topics included an update on the rationale and development of new agents for the treatment of osteoporosis, the use of bone turnover markers in clinical practice, hospital-based pathways for the management of hip fracture patients, injectable bisphosphonates for the treatment of osteoporosis, combination therapy with anabolic and antiresorptive agents, and assessment of skeletal health with devices other than central dual-energy X-ray absorptiometry. This is a collection of scientific essays based on presentations and discussions at the 2008 Santa Fe Bone Symposium.

Original languageEnglish
Pages (from-to)135-157
Number of pages23
JournalJournal of Clinical Densitometry
Volume12
Issue number2
DOIs
StatePublished - Apr 1 2009

Fingerprint

Osteoporosis
Bone and Bones
Bone Density Conservation Agents
Anabolic Agents
Bone Remodeling
Metabolic Bone Diseases
Photon Absorptiometry
Health
Hip Fractures
Diphosphonates
Therapeutics
Biomarkers
Clinical Trials
Equipment and Supplies
Injections

Keywords

  • BMD
  • bone turnover markers
  • FRAX
  • osteoporosis
  • review
  • treatment
  • update

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Lewiecki, E. M., Baim, S., Bilezikian, J. P., Eastell, R., LeBoff, M. S., & Miller, P. D. (2009). 2008 Santa Fe Bone Symposium: Update on Osteoporosis. Journal of Clinical Densitometry, 12(2), 135-157. https://doi.org/10.1016/j.jocd.2009.02.002

2008 Santa Fe Bone Symposium : Update on Osteoporosis. / Lewiecki, E. Michael; Baim, Sanford; Bilezikian, John P.; Eastell, Richard; LeBoff, Meryl S.; Miller, Paul D.

In: Journal of Clinical Densitometry, Vol. 12, No. 2, 01.04.2009, p. 135-157.

Research output: Contribution to journalArticle

Lewiecki, EM, Baim, S, Bilezikian, JP, Eastell, R, LeBoff, MS & Miller, PD 2009, '2008 Santa Fe Bone Symposium: Update on Osteoporosis', Journal of Clinical Densitometry, vol. 12, no. 2, pp. 135-157. https://doi.org/10.1016/j.jocd.2009.02.002
Lewiecki EM, Baim S, Bilezikian JP, Eastell R, LeBoff MS, Miller PD. 2008 Santa Fe Bone Symposium: Update on Osteoporosis. Journal of Clinical Densitometry. 2009 Apr 1;12(2):135-157. https://doi.org/10.1016/j.jocd.2009.02.002
Lewiecki, E. Michael ; Baim, Sanford ; Bilezikian, John P. ; Eastell, Richard ; LeBoff, Meryl S. ; Miller, Paul D. / 2008 Santa Fe Bone Symposium : Update on Osteoporosis. In: Journal of Clinical Densitometry. 2009 ; Vol. 12, No. 2. pp. 135-157.
@article{b2860fe9322d4e14b193f0385b31902e,
title = "2008 Santa Fe Bone Symposium: Update on Osteoporosis",
abstract = "The Ninth Annual Santa Fe Bone Symposium was held on August 1-2, 2008, in Santa Fe, New Mexico, USA. The symposium faculty presented the current best evidence on selected topics of clinical relevance in the fields of osteoporosis, metabolic bone disease, and assessment of skeletal health. The educational venues were in the form of didactic presentations, panel discussions, challenging cases, and numerous interactive discussions. Knowledge of basic science and clinical trials was applied to real-world patient scenarios that were discussed by faculty experts and clinician participants. Topics included an update on the rationale and development of new agents for the treatment of osteoporosis, the use of bone turnover markers in clinical practice, hospital-based pathways for the management of hip fracture patients, injectable bisphosphonates for the treatment of osteoporosis, combination therapy with anabolic and antiresorptive agents, and assessment of skeletal health with devices other than central dual-energy X-ray absorptiometry. This is a collection of scientific essays based on presentations and discussions at the 2008 Santa Fe Bone Symposium.",
keywords = "BMD, bone turnover markers, FRAX, osteoporosis, review, treatment, update",
author = "Lewiecki, {E. Michael} and Sanford Baim and Bilezikian, {John P.} and Richard Eastell and LeBoff, {Meryl S.} and Miller, {Paul D.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1016/j.jocd.2009.02.002",
language = "English",
volume = "12",
pages = "135--157",
journal = "Journal of Clinical Densitometry",
issn = "1094-6950",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - 2008 Santa Fe Bone Symposium

T2 - Update on Osteoporosis

AU - Lewiecki, E. Michael

AU - Baim, Sanford

AU - Bilezikian, John P.

AU - Eastell, Richard

AU - LeBoff, Meryl S.

AU - Miller, Paul D.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - The Ninth Annual Santa Fe Bone Symposium was held on August 1-2, 2008, in Santa Fe, New Mexico, USA. The symposium faculty presented the current best evidence on selected topics of clinical relevance in the fields of osteoporosis, metabolic bone disease, and assessment of skeletal health. The educational venues were in the form of didactic presentations, panel discussions, challenging cases, and numerous interactive discussions. Knowledge of basic science and clinical trials was applied to real-world patient scenarios that were discussed by faculty experts and clinician participants. Topics included an update on the rationale and development of new agents for the treatment of osteoporosis, the use of bone turnover markers in clinical practice, hospital-based pathways for the management of hip fracture patients, injectable bisphosphonates for the treatment of osteoporosis, combination therapy with anabolic and antiresorptive agents, and assessment of skeletal health with devices other than central dual-energy X-ray absorptiometry. This is a collection of scientific essays based on presentations and discussions at the 2008 Santa Fe Bone Symposium.

AB - The Ninth Annual Santa Fe Bone Symposium was held on August 1-2, 2008, in Santa Fe, New Mexico, USA. The symposium faculty presented the current best evidence on selected topics of clinical relevance in the fields of osteoporosis, metabolic bone disease, and assessment of skeletal health. The educational venues were in the form of didactic presentations, panel discussions, challenging cases, and numerous interactive discussions. Knowledge of basic science and clinical trials was applied to real-world patient scenarios that were discussed by faculty experts and clinician participants. Topics included an update on the rationale and development of new agents for the treatment of osteoporosis, the use of bone turnover markers in clinical practice, hospital-based pathways for the management of hip fracture patients, injectable bisphosphonates for the treatment of osteoporosis, combination therapy with anabolic and antiresorptive agents, and assessment of skeletal health with devices other than central dual-energy X-ray absorptiometry. This is a collection of scientific essays based on presentations and discussions at the 2008 Santa Fe Bone Symposium.

KW - BMD

KW - bone turnover markers

KW - FRAX

KW - osteoporosis

KW - review

KW - treatment

KW - update

UR - http://www.scopus.com/inward/record.url?scp=65449148304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449148304&partnerID=8YFLogxK

U2 - 10.1016/j.jocd.2009.02.002

DO - 10.1016/j.jocd.2009.02.002

M3 - Article

C2 - 19426925

AN - SCOPUS:65449148304

VL - 12

SP - 135

EP - 157

JO - Journal of Clinical Densitometry

JF - Journal of Clinical Densitometry

SN - 1094-6950

IS - 2

ER -